Active ingredientMirodenafilCat. No. P-M140-001CAS 862189-95-5Family · Pharmaceutical analytical standards
Mirodenafil
A phosphodiesterase 5 (PDE5) inhibitor developed in South Korea, where it was approved in 2007 for erectile dysfunction; in 2011 it was also introduced as an orally disintegrating film that dissolves in the mouth. This family brings together the active ingredient and labelled standards.
Did you know?In animal studies it crosses the blood-brain barrier: this is why it was taken into a phase 3 trial for early Alzheimer's disease, with more than 1,500 participants.
Go to the active ingredient →Active ingredientMirodenafilCat. No. P-M140-001CAS 862189-95-5
Isotopically labelledMirodenafil-d7Cat. No. P-M140-002CAS 1329651-11-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.